News | bioMérieux Asean countries

bioMérieux – First-Quarter 2021 Business Review

27 April, 2021

bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the three months ended March 31, 2021.

First-Half 2020 Results

02 September, 2020

Launch of BIOFIRE^® MYCOPLASMA test for mycoplasma detection in biopharmaceutical products

16 July, 2020

BIOFIRE^® Respiratory Panel 2.1 plus with SARS-CoV-2 is CE marked

15 July, 2020

CE marking of bioMérieux serology tests for SARS-CoV-2 on VIDAS^®

27 May, 2020

bioMérieux serology tests for SARS-CoV-2 on VIDAS^® undergo validation preceding imminent launch

06 May, 2020

BIOFIRE^® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 obtains FDA Emergency Use Authorization

04 May, 2020

First-Quarter 2020 Business Review

24 March, 2020

bioMérieux receives Emergency Use Authorization for BIOFIRE^® COVID-19 test

24 March, 2020

First of 3 diagnostic tests for SARS-CoV-2 coronavirus available from bioMérieux

11 March, 2020

Diagnostics is power